Scientists from the Tumor Immunotherapy and Microenvironment (TIME) research group led by Dr Bassam Janji at the Luxembourg Institute of Health (LIH) Department of Oncology (DONC), and the Swedish pharma company Sprint Bioscience published the results of an innovative approach that turns “cold” tumours “hot”.

The third module of the 2019/2020 curriculum of the CANBIO doctoral research and training programme ended on Friday, May 8th. It was the first set of lectures to be delivered entirely remotely due to the current COVID-19 pandemic.

On Friday, April 24th, the Luxembourg National Research Fund (Fonds National de la Recherche - FNR) announced the results of the first round of financing under its novel COVID-19 Fast Track Call.

CON-VINCE, a national research project aiming to evaluate the prevalence and dynamics of the spread of the COVID-19 disease within the Luxembourgish population, was launched at the beginning of April under the umbrella of the Research Luxembourg COVID-19 Task Force.

Scientists at the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) revealed a novel mechanism through which the immune system can control autoimmunity and cancer.

On Monday 4th May 2020, the Luxembourg Institute of Health (LIH) had the honor of welcoming Their Royal Highnesses the Grand Duke and the Grand Duchess of Luxembourg into the laboratories of the House of BioHealth in Esch- sur-Alzette.

The IT Technical Architect & Software Engineer will lead software architecture strategy,design and development by applying cutting edge engineering, testing anddelivery practices. He/She will ensure that Information Solutions supportingbusiness operations are available, secure, scalable, robust, high performantand cost efficient to serve both IBBL and partners. Lastly, he/she will also beresponsible for identifying standard methodologies to increase quality, reducecycle time & cost, increase visibility, and improve ability to adapt tochanging needs

Webinar: Digital Health Data in Personalized Medicine (Codex4SMEs)

Transversal Translational Medicine (TTM) at LIH creates a translational bridge between fundamental research and the clinic, where improved/advanced diagnosis, therapy and prevention may help patients in Luxembourg and beyond. Its overarching aim is to instil a transversal, translational and collaborative mind-set among researchers, healthcare practitioners and hospitals, allowing them to perform research that transcends the classical boundaries of individual diseases (the ‘transversal’ dimension) and that can be tangibly converted into improved diagnostics, therapies and interventions for patients (the ‘translational’ dimension).